[18] |
Miller R.Will succinylcholine ever disappear?[J].Anesth Analg,2004,98(6):1674-1675.
|
[19] |
Orebaugh SL.Succinylcholine:Adverse effects and alternatives in emergency medicine[J].Am J Emerg Med,1999,17(7):715-721.
|
[20] |
中国医师协会外科分会甲状腺外科医师委员会.甲状腺及甲状旁腺手术中神经电生理监测指南(中国版)[J].中国使用外科杂志,2013,33(6):470-474.
|
[24] |
刘溪,孙志荣,杨舒雯,等.舒更葡糖钠在甲状腺癌根治术神经监测中的应用[J].中国癌症杂志,2019,29(3):212-217.
|
[25] |
王宇,杨舒雯,李端树.甲状腺癌手术中喉返神经监测的临床应用[J].中国癌症杂志,2017,27(6):432-436.
|
[1] |
Benkhadoura M,Taktuk S,Alobedi R.Recurrent laryngeal nerve injury and hypoparathyroidism rates in reoperative thyroid surgery[J].Turk J Surg,2017,33(1):14-17.
|
[2] |
Jiang Y,Gao B,Zhang X,et al.Prevention and treatment of recurrent laryngeal nerve injury in thyroid surgery[J].Int J Clin Exp Med,2014,7(1):101-107.
|
[3] |
Barczyński M,Konturek A,Cichoń S.Randomized clinical trial of visualization versus neuromonitoring of recurrent laryngeal nerves during thyroidectomy[J].Br J Surg,2009,96(3):240-246.
|
[4] |
Chiang FY,Wang LF,Huang YF,et al.Recurrent laryngeal nerve palsy after thyroidectomy with routine identification of the recurrent laryngeal nerve[J].Surgery,2005,137(3):342-347.
|
[5] |
Chiang FY,Lu IC,Kuo WR,et al.The mechanism of recurrent laryngeal nerve injury during thyroid surgery--the application of intraoperative neuromonitoring[J].Surgery,2008,143(6):743-749.
|
[6] |
Vasileiadis I,Karatzas T,Charitoudis G,et al.Association of Intraoperative Neuromonitoring With Reduced Recurrent Laryngeal Nerve Injury in Patients Undergoing Total Thyroidectomy[J].JAMA Otolaryngol Head Neck Surg,2016,142(10):994-1001.
|
[7] |
Chiang FY,Lee KW,Chen HC,et al.Standardization of Intraoperative Neuromonitoring of Recurrent Laryngeal Nerve in Thyroid Operation[J].World J Surg,2010,34(2):223-229.
|
[8] |
Nakanishi T,Yoshimura M,Sakamoto S,et al.Postoperative laryngeal morbidity and intubating conditions using the McGRATH MAC videolaryngoscope with or without neuromuscular blockade:a randomised,double-blind,non-inferiority trial[J].Anaesthesia,2018,73(8):990-996.
|
[9] |
Combes X,Andriamifidy L,Dufresne E,et al.Comparison of two induction regimens using or not using muscle relaxant:impact on postoperative upper airway discomfort[J].Br J Anaesth,2007,99(2):276-281.
|
[10] |
N,R,I,et al.The incidence of difficult intubation in 2000 patients undergoing thyroid surgery--a single center expirience[J].Vojnosanit Pregl,2009,66(5):377-382.
|
[11] |
Bouaggad A,Nejmi SE,Bouderka MA,et al.Prediction of difficult tracheal intubation in thyroid surgery[J].Anesth Analg,2004,99(2):603-606,table of contents.
|
[12] |
Chang PY,Hu PY,Lin YC,et al.Trachway video intubating stylet allows for optimization of electromyographic endotracheal tube placement for monitored thyroidectomy[J].Gland Surg,2017,6(5):464-468.
|
[13] |
Mencke T,Echternach M,Kleinschmidt S,et al.Laryngeal morbidity and quality of tracheal intubation:a randomized controlled trial[J].Anesthesiology,2003,98(5):1049-1056.
|
[14] |
Mencke T,Knoll H,Schreiber JU,et al.Rocuronium is not associated with more vocal cord injuries than succinylcholine after rapid-sequence induction:a randomized,prospective,controlled trial[J].Anesth Analg,2006,102(3):943-949.
|
[15] |
Lu IC,Wu SH,Wu CW.Neuromuscular blockade management for intraoperative neural monitoring[J].Kaohsiung J Med Sci,2020,36(4):230-235.
|
[16] |
Randolph GW,Dralle H,International Intraoperative Monitoring Study Group,et al.Electrophysiologic recurrent laryngeal nerve monitoring during thyroid and parathyroid surgery:international standards guideline statement[J].Laryngoscope,2011,121 Suppl 1:S1-S16.
|
[17] |
Lu IC,Chang PY,Hsu HT,et al.A comparison between succinylcholine and rocuronium on the recovery profile of the laryngeal muscles during intraoperative neuromonitoring of the recurrent laryngeal nerve:a prospective porcine model[J].Kaohsiung J Med Sci,2013,29(9):484-487.
|
[21] |
Yu DJ,Gao HY.Influences of cisatracurium besylate and vecuronium bromide on muscle relaxant effects and electromyography of tracheal intubation under general anesthesia[J].Eur Rev Med Pharmacol Sci,2017,21(8):1974-1979.
|
[22] |
Chu KS,Wu SH,Lu IC,et al.Feasibility of intraoperative neuromonitoring during thyroid surgery after administration of nondepolarizing neuromuscular blocking agents[J].World J Surg,2009,33(7):1408-1413.
|
[23] |
Han YD,Liang F,Chen P.Dosage effect of rocuronium on intraoperative neuromonitoring in patients undergoing thyroid surgery[J].Cell Biochem Biophys,2015,71(1):143-146.
|
[26] |
Flockton EA,Mastronardi P,Hunter JM,et al.Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine[J].Br J Anaesth,2008,100(5):622-630.
|
[27] |
Empis de Vendin O,Schmartz D,Brunaud L,et al.Recurrent Laryngeal Nerve Monitoring and Rocuronium:A Selective Sugammadex Reversal Protocol[J].World J Surg,2017,41(9):2298-2303.
|
[28] |
Namizato D,Iwasaki M,Ishikawa M,et al.Anesthetic Considerations of Intraoperative Neuromonitoring in Thyroidectomy[J].J Nippon Med Sch,2019,86(5):263-268.
|
[29] |
Lu IC,Wu CW,Chang PY,et al.Reversal of rocuroniuminduced neuromuscular blockade by sugammadex allows for optimization of neural monitoring of the recurrent laryngeal nerve[J].Laryngoscope,2016,126(4):1014-1019.
|
[30] |
Donmez T,Erdem VM,Sunamak O,et al.Thyroid Surgery,Ionm and Sugammadex Sodium Relationships:Benefits in Sugammadex Sodium Use for Ionm[J].Acta Endocrinol(Buchar),2019,15(4):454-459.
|
[31] |
何志斌,王强,张明珠,等.舒更葡糖钠使甲状腺癌根治术中喉返神经监测信号快速恢复的半数有效剂量[J].中华麻醉学杂志,2020,40(1):71-73.
|
[32] |
Meistelman C,Plaud B,Donati F.Rocuronium(ORG 9426)neuromuscular blockade at the adductor muscles of the larynx and adductor pollicis in humans[J].Can J Anaesth,1992,39(7):665-669.
|
[33] |
Sorgenfrei IF,Norrild K,Larsen PB,et al.Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex-A dose-finding and safety study[J].Anesthesiology,2006,104(4):667-674.
|
[34] |
Kaufhold N,Schaller SJ,Stauble CG,et al.Sugammadex and neostigmine dose-finding study for reversal of residual neuromuscular block at a train-of-four ratio of 0.2(SUNDRO20)[J].Br J Anaesth,2016,116(2):233-240.
|
[35] |
Ledowski T,Hillyard S,Kozman A,et al.Unrestricted access to sugammadex:impact on neuromuscular blocking agent choice,reversal practice and associated healthcare costs[J].Anaesth Intensive Care,2012,40(2):340-343.
|